Roivant launched Lokavant with Parexel as first customer for real-time, anticipatory trial monitoring.
Trials fail from operational errors and lack real-time insight into execution. Lokavant offers real-time and anticipatory monitoring with risk alerts and machine learning prediction, trained on more than 1,000 clinical trials. Parexel signed a multi-year enterprise license; no results are stated.
Lokavant is a clinical trial intelligence company, spun out of Roivant, used by sponsors and CROs for risk monitoring and AI feasibility forecasting
This sits in the Ship stage of the AI use-case lifecycle: Named examples from the vendors pharma teams use to get an AI system live inside a real, regulated production workflow — validation, CRM, safety and clinical systems of record.
Published by Lokavant on its own site — read the original case study on clinicaltrialsarena.com ↗
Note: Launch article; no outcome figures.
Related use cases
- 01Lokavant's Spectrum turns trial feasibility planning into a live AI simulation, cutting analysis from five weeks to five minutes.
- 02Japanese CRO CMIC adopted Lokavant's machine learning Oversight platform to predict and manage trial risk.
- 03Transforming Content Operations for 2x Faster Time to Market
- 04Astellas: Breaking Access Barriers with Veeva Compliant Chat
- 05How Pacira Generated Deep Website Insights to Get Patients on Therapy Faster
- 06Reaching Underserved Communities with Smarter Targeting